No one is getting rich off of these prices. What about the $2.0 million from the Europeans? When that hits no one will be able to say scam. In fact they will say drug development and the entire narrative will change. The only thing holding things back are filing the financials because investors want the comfort that any real company would put the effort into filing the financials. I think they have but have had bad luck executing. But I would take execution on licensing any day over financial reporting. Licensing is the lifeblood of a company at this stage.
News 
Market Data 
Discover 
